Exploratory secondary analysis of published aggregate growth and metabolic data in children born small for gestational age treated with growth hormone.

What It Covers

Researchers studied Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in this review publication.

To describe published annual growth and metabolic summaries for children born small for gestational age (SGA) treated with growth hormone and to define the limits of inference from aggregate registry data.

Who the Included Studies Covered

The age groups tagged for this paper are young children and children, both men and women.

The researchers conducted an exploratory secondary analysis of published aggregate means, standard deviations, and outcome-specific sample sizes from baseline through year 5 in the SGA subgroup of the Korean LG Growth Study, with up to 318 children represented at baseline.

Primary reporting was descriptive and included annual values, changes from baseline, and measurement availability.

How the Review Was Done

Exploratory slope models were retained only as supplementary sensitivity analyses.

The published aggregate LGS summaries available for the present secondary analysis did not include longitudinal blood-pressure measurements or cardiovascular-event records.

What Was Measured

PubMed files the paper under topics including Infant, Small for Gestational Age, Human Growth Hormone, Secondary Data Analysis, Growth Disorders, Body Height and Child Development.

The authors tagged it with the keywords aggregate data analysis, ecological inference, metabolic surveillance, registry research, secondary analysis and somatropin.

What This Means in Plain Language

This is a review of Exogenous HGH, sermorelin & older GHRPs (why they're passed over).

Results are reported in around 5 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 2026 (Frontiers in endocrinology), a journal based in Switzerland.

More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.